Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-201704, 333-201705, 333-225995, 333-233349 and 333-258640 on Form S-3 and Registration Statement Nos. 333-131880, 333-168763, 333-175460, 333-182546, 333-198391, 333-213714, 333-228981 and 333-261598 on Form S-8 of our report dated April 1, 2024, relating to the financial statements of Brainstorm Cell Therapeutics Inc. appearing in this Annual Report on Form 10-K for the year ended December 31, 2023.
/s/ Brightman Almagor Zohar & Co. |
| |
| | |
Brightman Almagor Zohar & Co. | | |
Certified Public Accountants | | |
A Firm in the Deloitte Global Network | | |
| | |
Tel Aviv, Israel | | |
April 1, 2024 | | |